Literature DB >> 10844599

Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells.

M Ruiz-Ortega1, O Lorenzo, J Egido.   

Abstract

BACKGROUND: Monocyte infiltration is a common feature of renal diseases. Angiotensin II (Ang II) participates in inflammatory cell infiltration in the kidney. However, the influence of other peptides of the renin-angiotensin system, such as the N-terminal Ang II degradation product Ang III, has not been addressed.
METHODS: In cultured renal and mononuclear cells, we investigated whether Ang III is involved in monocyte recruitment through the regulation of the chemokine, monocyte chemoattractant protein-1 (MCP-1; Northern blot, Western blot, immunofluorescence, and chemotaxis), and the activation of transcription factors, nuclear factor kappaB (NF-kappaB) and activating protein-1 (AP-1; electrophoretic mobility shift assay).
RESULTS: In cultured rat mesangial and mononuclear cells, Ang III increased MCP-1 gene expression and protein levels. Supernatants from Ang III-treated mesangial cells showed increased chemoattractant activity for monocytes, which was partially inhibited by the addition of anti-MCP-1 antibody. Ang III elicited a rapid NF-kappaB activation (8-fold, after 30 min), showing a kinetics and intensity similar to that observed with Ang II and tumor necrosis factor-alpha. The maximal NF-kappaB activation was correlated with nuclear translocation of p50 and p65 subunits and disappearance of cytosolic IkappaB. Ang III also activated AP-1 (5-fold, after 18 h), while SP-1 was unchanged. Two NF-kappaB inhibitors abolished the Ang III-induced MCP-1 mRNA expression, suggesting that overexpression of this chemokine is mediated, at least in part, by NF-kappaB activation.
CONCLUSIONS: Ang III activates the transcription factors NF-kappaB and AP-1 and increases the expression of related genes, such as MCP-1. Our study describes a novel and potent proinflammatory action of this Ang degradation product, expanding the present view of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844599     DOI: 10.1046/j.1523-1755.2000.00089.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  Angiotensin III induces c-Jun N-terminal kinase leading to proliferation of rat astrocytes.

Authors:  Michelle A Clark; Chinh Nguyen; Hieu Tran
Journal:  Neurochem Res       Date:  2012-03-08       Impact factor: 3.996

2.  HIV-associated nephropathy: role of AT2R.

Authors:  Divya Salhan; Ankita Sagar; Dileep Kumar; Rungwasee Rattanavich; Partab Rai; Subani Maheshwari; Madhuri Adabala; Mohammad Husain; Guohua Ding; Ashwani Malhotra; Praveen N Chander; Pravin C Singhal
Journal:  Cell Signal       Date:  2011-11-13       Impact factor: 4.315

3.  A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Gregory Sprung; Robert Griffiths; Matthew Sparks; Ming Yan; James L Burchette; David N Howell; Eugene E Lin; Benson Okeiyi; Johannes Stegbauer; Yanqiang Yang; Pierre-Louis Tharaux; Phillip Ruiz
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

Review 4.  Pathogenesis and therapeutic implications of cardiorenal syndrome.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2010-11-23       Impact factor: 2.801

Review 5.  Angiotensin II and the glomerulus: focus on diabetic kidney disease.

Authors:  James W Scholey
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 6.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 7.  Molecular mechanisms of angiotensin II-induced vascular injury.

Authors:  Marta Ruiz-Ortega; Monica Ruperez; Vanesa Esteban; Jesús Egido
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  The cardiorenal syndrome: making the connection.

Authors:  Gautham Viswanathan; Scott Gilbert
Journal:  Int J Nephrol       Date:  2010-10-04

9.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Authors:  Timothy D Wiggin; Matthias Kretzler; Subramaniam Pennathur; Kelli A Sullivan; Frank C Brosius; Eva L Feldman
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

10.  Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.

Authors:  Steven D Crowley; Campbell W Frey; Samantha K Gould; Robert Griffiths; Phillip Ruiz; James L Burchette; David N Howell; Natalia Makhanova; Ming Yan; Hyung-Suk Kim; Pierre-Louis Tharaux; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.